LAUSR

Introduction/Background Groin pain in athletes is a common problem. The use of botulinum toxin (BTX) has shown good results in neuromuscular diseases and more recently in pathologies such as epicondylitis. The aim was to assess the effectiveness and side effects of the BTX injections in adductor related groin pain, which resists to rehabilitation and/or surgery. A pilot study with one year follow-up. Material and method Between March 2014 and April 2016 we systematically registered patients who received BTX injections in adductor muscles under both control by ultrasound and electrostimulation. We carried out a follow-up at 1, 3, 6 and 12 months on pain intensity, HAGOS scores, professional disability, and side effect recording. Results Thirty patients, 83% males and 17% females have been included. Adductor tenotomy was recorded in 14 patients before the injection. Pain intensity decreased significantly (D0: 65 ± 16 mm; D30 31 ± 23; D90 28 ± 23; D180 33 ± 28; D36531 ± 30; P  Conclusion This present study suggests that BTX is an effective treatment for the adductor related groin pain with no side effect and a low rate of recurrence.